Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Thiourea is a compound that can be found in the amino acid threonine. It is also produced by certain bacteria, such as Lactobacillus acidophilus. Thiourea has been shown to have a variety of potential health benefits, including relief from celiac disease symptoms and the formation of body tissues. Thiourea may also serve as a nutritional supplement for animals and humans, although it is not well-studied in this area. The low molecular weight and divalent nature of thiourea makes it soluble in water and thus highly absorbable by the intestines.</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Patent US20100287939</p>

<p>(2-Chloroethyl)trimethylsilane is an organosilicon compound with a molecular weight of 98.06 g/mol. It is synthesized from ethylene and chlorine, and has been shown to inhibit the activity of tyrosine kinase in chronic pain and depression models. (2-Chloroethyl)trimethylsilane also inhibits adenosine receptors, which are involved in the development of chronic pain. This drug has been shown to be effective against depression by inhibiting the binding of adenosine to its receptor site. The kinetic properties of this drug have been studied using molecular modelling, and it has been found that conformational changes are induced in the purinergic receptor when this drug binds.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>(2S)-2-(Dimethylamino)-3-(4-hydroxyphenyl)propanoic acid is a potent antagonist of the ryanodine receptor (RYR), which is a calcium release channel in the sarcoplasmatic reticulum. It has been shown to inhibit neuronal death induced by oxidative injury and also to protect against mitochondrial dysfunction. This compound has also been found to be an antinociceptive agent and is detectable at low concentrations in vivo. The pharmacokinetic properties of this drug are not well understood, but it appears to be rapidly absorbed from the gastrointestinal tract and eliminated via the urinary system.</p>

<p>2,2,2-Trifluoroethoxybenzene is an acid catalyst that is used in the production of chlorobenzene. This organic compound has been shown to produce a number of products when heated with dihydroxybenzene. These products include acid chlorides and benzoyl chloride that can be used as intermediates in other chemical reactions. 2,2,2-Trifluoroethoxybenzene has also been shown to react with alkali metals to produce inorganic acids. In addition to acting as an acid catalyst, this compound may be used in the synthesis of flecainide, which is an antiarrhythmic drug. This product also reacts with carbonyl groups and acidic molecules such as halogens to form alkali metal carboxylates and alkanes.</p>

<p>Versatile small molecule scaffold</p>

<p>1-(5-Methyl-1H-pyrazol-3-yl)ethanone is an experimental compound that belongs to the class of pyridazines. The molecule was first synthesized in 1933 and it has been studied for its photochemical properties. The structure of 1-(5-methyl-1H-pyrazol-3-yl)ethanone consists of a pyrazole ring fused to an ethanone bearing a methyl substituent. It has been shown that irradiation with UV light causes the molecule to react with dichloromethane, leading to the formation of a series of intermediates, such as chloromethanes, dichloroethylenes, and benzene.</p>

<p>Versatile small molecule scaffold</p>